What happens when organization of cervical cancer screening is delayed or stopped?

Journal of Medical Screening

Volumn 13, Issue 1, 2006, Pages 41-46

  Lynge, Elsebeth ^a   Clausen, Lene Bjørk ^a   Guignard, Romain ^a   Poll, Paul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; DENMARK; FEMALE; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POISSON DISTRIBUTION; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; AGE; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCER; RISK FACTOR; RISK MANAGEMENT; STATISTICAL MODEL; TIME; UTERINE CERVIX TUMOR;

ADULT; AGE FACTORS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; PRECANCEROUS CONDITIONS; RISK FACTORS; RISK MANAGEMENT; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33646848440     PISSN: 09691413     EISSN: 09691413     Source Type: Journal    
DOI: 10.1258/096914106776179773     Document Type: Article

References (20)

1. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-86
2. Sundhedsstyrelsen. Prophylactic Examinations of the Cervix Uteri. København: Sundhedsstyrelsen, 1986 (in Danish)
3. Lynge E. Regional differences in smear-taking and cervical cancer incidence in Denmark 1943-1982. Ugeskr Læger 1984;146:3477-3482 (in Danish, abstract in English)
4. Lynge E, Arffmann E, Hansen KC, et al. The status for prophylactic examinations for cancer of the uterine cervix in Denmark in 1991. Ugeskr Læger 1992;154:1339-42 (in Danish, abstract in English)
5. Lynge E, Arffmann A, Erbs K, et al. Cervical cancer screening in Denmark: status. Ugeskr Læger 1994;156:471-3 (in Danish, abstract in English)
6. Lynge E, Arffmann A, Behnfeld L, et al. Cervical cancer screening in Denmark: status in 1995 and plans for 1996. Ugeskr Læger 1996;158:4916-19 (in Danish)
7. Lynge E, Poll P, Larsen J, et al. Screening for cancer of the uterine cervix in three Danish counties during the period 1979-1989. Ugeskr Læger 1992;154:1335-8 (in Danish, abstract in English)
8. Coleman D, Day N, Douglas G, et al. European guidelines for quality assurance in cervical cancer screening. Eur J Cancer 1993;29A(Suppl. 4):1-38
9. Sundhedsstyrelsen. Cancer in Denmark. København: Sundhedsstyrelsen, 2005 (in Danish)
10. van Ballegooijen M, van den Akker-van Merle E, Parnick J, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000;36:2177-88
11. Junge J. Cervical cancer screening in Copenhagen and Frederiksberg. København: H:S Hvidovre Hospital, 2005 (in Danish)
12. Gustafsson L, Sparén P, Gustafsson M, et al. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer 1995;72:498-505
13. Nieminen P, Kallio M, Antilla A, Hakama M. Organised vs. spontaneous pap-smear screening for cervical cancer: a case-control study. Int J Cancer 1999;83:55-8
14. Lynge E. Regional trends in incidence of cervical cancer in Denmark in relation to local smear-taking activity. Int J Epidemiol 1983;12:405-13
15. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:904-8
16. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening had prevented in the UK. Lancet 2004;364:249-56
17. Karnon J, Peters J, Platt J, et al. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess 2004;8:1-78
18. Schiffmann M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003;127:946-9
19. Bulkmans NW, Rozendaal L, Snijders PJ, et al. POBASCAM, a population-based randomised controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004;110:94-101
20. Kotaniemi-Talonen L, Nieminen P, Anttila A, et al. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 2005;93:862-7